Published in Lancet on September 01, 1973
Serology and epidemiology. West J Med (1975) 0.75
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77
A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med (1967) 7.00
Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci U S A (1975) 6.68
Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med (1968) 4.28
The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol (1975) 2.39
Australia antigen and hepatitis. N Engl J Med (1970) 2.35
Australia antigen and acute viral hepatitis. Ann Intern Med (1969) 2.20
Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technic. Nature (1969) 1.97
Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA (1968) 1.94
Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A (1969) 1.84
Australia antigen and hepatitis. JAMA (1969) 1.81
Australia antigen as a hepatitis virus. Variation in host response. Am J Med (1970) 1.69
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma. Lancet (1975) 1.62
Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci U S A (1987) 1.52
Sex distribution of Australia antigen. Arch Intern Med (1972) 1.52
Australia antigen (a hepatitis-associated antigen): purification and physical properties. J Exp Med (1970) 1.46
The localization of Australia antigen by immunofluorescence. J Exp Med (1970) 1.42
Radioimmunoprecipitation assay for Australia antigen, antibody, and antigen-antibody complexes. Proc Soc Exp Biol Med (1971) 1.38
Australia antigen-antibody complexes. Nature (1970) 1.32
The monoglyceride pathway of fat absorption in man. J Clin Invest (1967) 1.24
Detection of Australia antigen in human tissue culture preparations. Proc Soc Exp Biol Med (1971) 1.23
Specificities of human antibodies to Australia antigen. Proc Soc Exp Biol Med (1970) 1.20
A newly identified hepatitis B type virus in tree squirrels. Proc Natl Acad Sci U S A (1986) 1.18
Brown bowel and skeletal myopathy associated with vitamin E depletion in pancreatic insufficiency. Gastroenterology (1968) 1.17
Australia antigen: physical and chemical properties. Res Commun Chem Pathol Pharmacol (1972) 1.16
Australia antigen: detection and transmission in shellfish. Science (1974) 1.13
Persistence of hepatitis B surface antigen in the bedbug Cimex hemipterus (Fabr.). J Infect Dis (1979) 1.13
Reversible protein-losing enteropathy with intestinal lymphangiectasia secondary to chronic constrictive pericarditis. N Engl J Med (1965) 1.11
Virus-like particles in Australia antigen-associated hepatitis. An immunoelectron microscopic study of human liver. Am J Pathol (1972) 1.08
The health care system in India. Ann Intern Med (1980) 1.07
Effects of host and environment on immunoglobulins in Down's syndrome. Arch Intern Med (1969) 1.07
Glycoproteins of natural origin with an affinity for hepatitis B surface antigen. Infect Immun (1978) 1.07
Australia antigen and antibody in transfused children with thalassaemia. Arch Dis Child (1972) 1.06
Cancer in India. N Engl J Med (1980) 1.06
Letter: Elevated serum iron levels and persistent Australia antigen (HBsAG). Ann Intern Med (1974) 1.06
Bile salt regulation of fatty acid absorption and esterification in rat everted jejunal sacs in vitro and into thoracic duct lymph in vivo. J Clin Invest (1969) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Australia antigen (a hepatitis-associated antigen) in leukemia. J Natl Cancer Inst (1970) 1.03
Woodchuck hepatitis virus: experimental infection and natural occurrence. Hepatology (1984) 1.03
Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections. J Med Virol (1988) 1.03
Australia antigen in chronic active liver disease with cirrhosis. Lancet (1969) 1.02
Distribution of d-xylose in sequestered fluid resulting in false-positive tests for malabsorption. Ann Intern Med (1968) 1.02
Australia antigen, posttransfusion hepatitis, and the chronic carrier state. Am J Dis Child (1972) 1.01
The incorporation of radioactive uridine into the hepatitis B antigen of a chimpanzee. Proc Soc Exp Biol Med (1975) 1.01
Progressive familial cholestatic cirrhosis and bile acid metabolism. J Pediatr (1972) 0.99
Viral hepatitis. Revised concepts as a result of the study of Australia antigen. Med Clin North Am (1970) 0.98
Australia antigen: a genetic basis for chronic liver disease and hepatoma? Ann Intern Med (1971) 0.96
Lymphocyte transformation and hepatitis. I. Impairment of thymidine incorporation and DNA polymerase activity. Proc Soc Exp Biol Med (1971) 0.96
The production of antibodies to Australia antigen in mouse ascites fluid. Proc Soc Exp Biol Med (1970) 0.95
Persistent anicteric hepatitis with Australia antigen in patients with Down's syndrome. Am J Clin Pathol (1972) 0.93
Lymphocyte function in normal people with persistent Australia antigen. J Lab Clin Med (1973) 0.93
Ergasteric hepatitis: endemic hepatitis associated with Australia antigen in a research laboratory. Ann Intern Med (1971) 0.92
Comparison of progeny of mothers with and without Australia antigen. Hum Biol (1972) 0.92
Susceptibility to leukemia: immunologic factors in Down's syndrome. J Natl Cancer Inst (1971) 0.91
Australia antigen and the quest for a hepatitis virus. Am J Dig Dis (1969) 0.91
Effects of secretin and bile salt infusions on canine bile composition and flow. Am J Physiol (1972) 0.90
Australia antigen and the immune response in human diseases. J Allergy Clin Immunol (1974) 0.90
Australia antigen and viral hepatitis in drug abusers. Arch Intern Med (1971) 0.90
Australia antigen and hepatitis: a comprehensive review. CRC Crit Rev Clin Lab Sci (1971) 0.90
Automated complement fixation test for the detection of antibodies against the core of hepatitis B virus (HBc). J Immunol Methods (1976) 0.89
Immunological cross-reactivities of woodchuck and hepatitis B viral antigens. Infect Immun (1982) 0.89
DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome. J Clin Invest (1970) 0.89
Frequency of Australia antigen in patients with leukaemia in different countries. Lancet (1971) 0.89
Evaluation of corticosteroid and exchange-transfusion treatment of acute yellow-phosphorus intoxication. N Engl J Med (1971) 0.89
Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology (1991) 0.88
Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus. Carcinogenesis (1989) 0.88
Granulocyte function and levels of immunoglobulins and complement in patients admitted for withdrawal from alcohol. J Infect Dis (1978) 0.88
Definition of a responder in clinical trials for functional gastrointestinal disorders: report on a symposium. Gut (1999) 0.87
Effect of the H37Ra strain of M. tuberculosis and of a mycobacterial RNA fraction on tumor growth. Proc Soc Exp Biol Med (1974) 0.87
Lymphocyte transformation and hepatitis. II. Lack of direct in vitro inhibition by purified Australia antigen. Proc Soc Exp Biol Med (1971) 0.87
Intestinal fatty acid absorption and esterification from luminal micellar solutions containing deoxycholic acid. Proc Soc Exp Biol Med (1970) 0.87
Liver biopsies in patients with and without Australia antigen. Arch Pathol (1972) 0.87
A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes. Immunol Cell Biol (1990) 0.87
Association of antibodies to Australia antigen with anti-Gm antibodies in Italian patients with thalassaemia. Nature (1972) 0.87
Hepatitis-B virus in bedbugs (Cimex hemipterus) from Senegal. Lancet (1977) 0.86
Interrelationship of bile salts, phospholipids, and cholesterol in bile during manipulation of the enterohepatic circulation in the conscious dog. Gastroenterology (1973) 0.86
Australia antigen in the Solomon Islands. Hum Biol (1974) 0.85
Tree squirrel hepatitis B virus: antigenic and structural characterization. Proc Natl Acad Sci U S A (1986) 0.85
New immunologic relationships of Australia antigen. Vox Sang (1971) 0.84
Metabolism of canine small intestine vascularly perfused in vitro. J Appl Physiol (1969) 0.83
The use of nitrocellulose blotting for the study of hepatitis B surface antigen electrophoresed in agarose gels. J Immunol Methods (1981) 0.83
Lymphocyte transformation and persistent Australia antigen. Lancet (1973) 0.83
Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions. Cancer Res (1977) 0.83
Hepatitis B virus and hepatocellular carcinoma--treatment of HBV carriers with Phyllanthus amarus. Cancer Detect Prev (1989) 0.83
Studies of parents of children with acute leukemia. J Natl Cancer Inst (1975) 0.83
Lessons learned from six years of international administrations of the ECFMG's SP-based clinical skills assessment. Acad Med (1998) 0.83
Genetics of albumin Gainesville, a new variant of human serum albumin. Nature (1969) 0.83
The role of Australia antigen in viral hepatitis and other diseases. Annu Rev Med (1972) 0.82